Bliss GVS Pharma Ltd. (BLISSGVS-BE): Bliss GVS Pharma Share Price Rises 5% Today to Rs 587.05
- August 28, 2026
- Posted by: Harsh Piplani
- Category: News
Bliss GVS Pharma Share Price rose today as the stock closed at Rs 587.05, up 5% from the previous close of Rs 559.10, with market capitalisation at Rs 6,066.19 Cr. The day’s gain of Rs 27.95 followed an open at Rs 569.80, a high of Rs 587.05 and a low of Rs 553.10. The data confirms a same-day price rise, but it does not establish a company-specific catalyst. For investors tracking Bliss GVS Pharma Share Price Today, the move is relevant because it places the stock among today’s notable gainers while keeping fundamentals, sector valuation and peer positioning in view. Univest is covering the stock through a factual price, ratio and comparison lens, so readers can follow Bliss GVS Pharma Stock News without assuming a reason that is not verified.
In market terms, Bliss GVS Pharma Share Price News is being shaped by the visible move in price and the company’s valuation profile rather than any stated event trigger. The stock’s turnover stood at Rs 0.59 Cr, which is a factual traded-value metric and should be read alongside the day’s price action. Univest notes that the move is best understood through a combination of current price, market capitalisation, P/E, P/B, profitability ratios and sector benchmarks.
Bliss GVS Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 587.05 |
| Previous Close | Rs 559.1 |
| Today's Move | Rs 27.95 (+5%) |
| Open | Rs 569.8 |
| High | Rs 587.05 |
| Low | Rs 553.1 |
| Turnover | Rs 0.59 crore |
| Market Capitalisation | Rs 6,066.19 crore |
| Market Cap Category | Mid Cap |
Bliss GVS Pharma Ltd. (BLISSGVS-BE) rose to Rs 587.05 from the previous close of Rs 559.1, a move of Rs 27.95 or 5%. The stock opened at Rs 569.8, reached a high of Rs 587.05, recorded a low of Rs 553.1.
Bliss GVS Pharma Share Price Today showed a clear rise in same-day trading, with the stock advancing to Rs 587.05 from Rs 559.10. The gain of Rs 27.95 equals 5%, and the stock also matched the day’s high of Rs 587.05 after opening at Rs 569.80. The low for the session was Rs 553.10. These figures show that Bliss GVS Pharma Stock News is centred on a visible price move, while the supplied data does not identify a company-specific reason for the change. For readers following Bliss GVS Pharma Share Price Live, the key takeaway is simply the measured price rise and where the stock closed within the session range.
Bliss GVS Pharma Ltd. (BLISSGVS-BE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 6,066.19 crore |
| P/E Ratio | 43.63x |
| P/B Ratio | 4.82x |
| ROE | 12.11% |
| ROCE | 17.4% |
| EPS | Rs 12.81 |
| Book Value Per Share | Rs 116 |
| Dividend Yield | 0.27% |
Bliss GVS Pharma Ltd. (BLISSGVS-BE) fundamental metrics show P/E 43.63x, P/B 4.82x, ROE 12.11%, ROCE 17.4%. These figures provide context only and are not a buy or sell signal.
Bliss GVS Pharma Ltd. has a market capitalisation of Rs 6066.19 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 43.63x, P/B at 4.82x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.11% and ROCE of 17.4%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 12.81, book value per share of Rs 116, dividend yield of 0.27%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.16x, median ROE of 11.82%, median ROCE of 13.71%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 43.63x |
| Benchmark Median P/E | 31.16x |
| Benchmark Average P/E | 48.05x |
| Benchmark P/E Range | 3.36x to 397.25x |
| Company P/B Ratio | 4.82x |
| Benchmark Median P/B | 2.71x |
| Company ROE | 12.11% |
| Benchmark Median ROE | 11.82% |
| Company ROCE | 17.4% |
| Benchmark Median ROCE | 13.71% |
| Company Market Capitalisation | Rs 6,066.19 crore |
| Benchmark Median Market Cap | Rs 664.09 crore |
Bliss GVS Pharma Ltd. (BLISSGVS-BE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a P/E ratio of 43.63x, which is above the benchmark median of 31.16x, a difference of +40.02%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a ROE of 12.11%, which is above the benchmark median of 11.82%, a difference of +2.45%. Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a ROCE of 17.4%, which is above the benchmark median of 13.71%, a difference of +26.91%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,56,113.58 | 37.7 | 5.27 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,39,321.25 | 82.14 | 13.6 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,85,923.81 | 87.64 | 21.3 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,14,508.45 | 26.28 | 4.4 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,13,778.04 | 34.03 | 3.26 | 11.83 | 16 |
Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a P/E ratio of 43.63x compared with the displayed peer median of 37.7x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.11% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 17.4% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a market capitalisation of Rs 6,066.19 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Bliss GVS Pharma
- Bliss GVS Pharma Share Price rose 5% today to Rs 587.05, with a gain of Rs 27.95 over the previous close of Rs 559.10.
- The stock opened at Rs 569.80, touched Rs 553.10 as the low and finished at the session high of Rs 587.05.
- Market capitalisation stood at Rs 6,066.19 Cr, which gives scale context to the day’s Bliss GVS Pharma Stock News.
- P/E is 43.63 and P/B is 4.82, both above the sector median for the same-industry benchmark set.
- ROE is 12.11 and ROCE is 17.40, both above the benchmark median, while EPS is Rs 12.81 and book value is Rs 116.
About Bliss GVS Pharma
Bliss GVS Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s business profile, as reflected in this article, is pharmaceutical in nature and sits within a broad listed universe of 201 same-industry companies used for benchmark comparison. Investors following Bliss GVS Pharma Share News often look at the stock through the lens of valuation, profitability and market capitalisation rather than through a single day’s move alone.
As a listed pharma company, Bliss GVS Pharma Share Price is relevant to readers who track the Indian Stock Market for healthcare names that report measurable earnings and book-value support. Its exact disclosed ratios include P/E, P/B, ROE, ROCE, EPS, book value and dividend yield, which help position the company in relation to peers. Univest uses those figures to present a factual company overview and stock analysis, not an investment opinion.
Track Bliss GVS Pharma Share Price on Univest
Use Bliss GVS Pharma Ltd. (BLISSGVS-BE) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
You can track Bliss GVS Pharma Share Price on Univest for live price updates, key valuation ratios, shareholding pattern, company fundamentals, 52-week levels and market insights in one place. Univest also helps readers follow Bliss GVS Pharma Stock Analysis and Bliss GVS Pharma Latest News alongside sector and peer comparison.
For users searching Bliss GVS Pharma Share Price Today or Bliss GVS Pharma NSE updates, Univest presents a clean view of the stock’s price action and financial context. If you are reviewing Bliss GVS Pharma BSE movement, Univest keeps the data structure consistent so the article, ratios and market snapshot remain easy to scan.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Bliss GVS Pharma Share Price rise today?
Ans. Bliss GVS Pharma Share Price rose 5% today to Rs 587.05, but the supplied data does not establish a company-specific catalyst. The move is confirmed by the day’s price, open, high, low and previous close.
What is Bliss GVS Pharma Share Price today?
Ans. Bliss GVS Pharma Share Price today is Rs 587.05. It is up Rs 27.95, or 5%, from the previous close of Rs 559.10, with the stock ending at the day’s high.
What is Bliss GVS Pharma market cap today?
Ans. Bliss GVS Pharma market cap today is Rs 6,066.19 Cr. That places the company above the sector median market cap in the same-industry benchmark set, while remaining far below the industry leaders.
How is Bliss GVS Pharma valued versus peers?
Ans. Bliss GVS Pharma Share Price is supported by a P/E of 43.63 and P/B of 4.82. Both are above the sector median, while ROE and ROCE are also above benchmark medians.
What do Bliss GVS Pharma fundamentals show?
Ans. Bliss GVS Pharma Fundamental Analysis shows EPS of Rs 12.81, book value of Rs 116 and dividend yield of 0.27%. These figures add context to today’s share price rise and valuation profile.
How does Bliss GVS Pharma compare with sector benchmarks?
Ans. In the same-industry benchmark of 201 companies, Bliss GVS Pharma’s P/E and P/B are above the median, while ROE at 12.11 and ROCE at 17.40 are also above the benchmark medians.
